Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the Polypill for Prevention of Cardiovascular Diseases With Focus on Non-Alcoholic Steatohepatitis: The Polyiran-Liver Trial

Abbas Mohagheghi Dare Ranj

Associate Professor of Cardiology

Department Cardiology

School of Medicine

Shariati Hospital

Tehran University of Medical Sciences

Related Documents

1. Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Disease: A Pragmatic Cluster-Randomised Controlled Trial (Polypars), Heart (2024)

2. Preventive Effects of a Cvd Polypill on Developing Diabetes Among Patients With Metabolic Syndrome: Results of the Polyiran-Liver Trial, Archives of Iranian Medicine (2024)

All Documents

1. Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Disease: A Pragmatic Cluster-Randomised Controlled Trial (Polypars), Heart (2024)

2. Preventive Effects of a Cvd Polypill on Developing Diabetes Among Patients With Metabolic Syndrome: Results of the Polyiran-Liver Trial, Archives of Iranian Medicine (2024)

3. Orrelation Between Type Ii Diabetes and Left Heart Function Utility of the Right Ventricular Early Inflow-Out Flow Index in the Assessment of Mortality in Covid-19 Bayat Et Al, Iranian Heart Journal (2021)

4. The Incidence of Myopericarditis in Patients With Covid-19, Journal of Cardiovascular and Thoracic Research (2021)

5. Effect of Tricuspid Valve Repair in Patients With Moderate Tricuspid Regurgitation Undergoing Left-Sided Valve Surgery, Archives of Iranian medicine (2019)

6. Association Between Metabolic Syndrome and Coronary Artery Stent Stenosis, Iranian Heart Journal (2015)

7. Trastuzumab-Induced Cardiomyopathy Evaluation by Combined Echocardiography and Biomarkers in Patients With Breast Cancer, Iranian Heart Journal (2015)

8. Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients With St-Segment Elevated Myocardial Infarction: A Prospective Open Label Pilot Clinical Trial, Iranian Journal of Pharmaceutical Research (2014)